Spago Nanomedical AB (publ) (STO:SPAGO)
Sweden
· Delayed Price · Currency is SEK 0.116
-0.011 (-8.33%)
Mar 9, 2026, 5:29 PM CET
Spago Nanomedical AB Revenue
In the year 2025, Spago Nanomedical AB had annual revenue of 4.82M SEK, down -27.53%. Spago Nanomedical AB had revenue of 833.00K in the quarter ending December 31, 2025, a decrease of -55.07%.
Revenue
4.82M
Revenue Growth
-27.53%
P/S Ratio
15.85
Revenue / Employee
688.86K
Employees
7
Market Cap
76.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.82M | -1.83M | -27.53% |
| Dec 31, 2024 | 6.65M | 1.01M | 17.94% |
| Dec 31, 2023 | 5.64M | -562.00K | -9.06% |
| Dec 31, 2022 | 6.20M | -279.00K | -4.30% |
| Dec 31, 2021 | 6.48M | -679.00K | -9.48% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biovica International AB | 9.89M |
| Scandinavian ChemoTech AB | 12.29M |
| OncoZenge AB | 2.78M |
| Biosergen AB | 2.09M |
| Alligator Bioscience AB | 4.42M |
| Alzinova AB | 26.12M |
| Xbrane Biopharma AB | 152.35M |
| Pila Pharma AB | 1.13M |